Histogenics Corporation Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Histogenics is a biotechnology research company based in Waltham, Massachusetts, focused on personalized restorative cell therapies for active living. Its leading candidate, NeoCart, is designed to reconstruct a patient's knee cartilage using a patient-specific approach, with the aim of reducing pain at the source and potentially slowing progression to osteoarthritis. The work centers on regenerating tissue within the joint to restore function rather than merely managing symptoms.

Histogenics serves patients with knee joint damage who may benefit from cartilage restoration, operating within the biotech research sector. In 2019, the company was acquired by Ocugen, integrating its work into a broader organization. The firm has a small team and continues development activities related to NeoCart.

Sign up for free to view info

Company overview Employee directory